The National Institutes of Health confirmed on Feb. 10 that it is funding studies exploring whether ivermectin can help cancer patients.
“Ivermectin, a macrocyclic lactone discovered in the mid-1970s, plays a critical role in the treatment of a wide range of parasitic diseases in humans as well as in veterinary practice,” the NIH said in a statement.





